Canine Oral Chewable Tablets Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Canine Oral Chewable Tablets Market by Composition Type (Botanically synthesized, Chemically synthesized), by Drug Class (Analgesics, Anti-infective, Anti-ulcers, Vitamins & minerals, Cardiovascular drugs, Others), by Application (Gastrointestinal diseases, Cardiovascular disorders, Infectious diseases, Nutritional supplements, Others), by Product Type (Prescription, Over the Counter (OTC)), by Distribution Channel (Veterinary clinics, Veterinary Pharmacies, Online veterinary stores, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Canine Oral Chewable Tablets Market are the oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and fleas infections, and among others. Various additives and flavouring agents are used in the formulation of canine oral chewable tablets for masking the unpleasant taste and odour of the drugs. The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately. The global canine oral chewable tablets market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the global market. For instance, in December 2015, Boehringer Ingelheim acquired Merial (Sanofi animal health) for strengthening its product portfolio. In addition, in May 2014, Merck Animal Health received the FDA approval for its drug Bravecto (fluralaner) used in the treatment of fleas and ticks infections. Moreover, in December 2014, Putney, Inc. launched the Carprofen canine oral chewable tablets for the treatment of pain and inflammation.

Canine Oral Chewable Tablets Market

MARKET SUMMARY
-
x%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– x%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Canine Oral Chewable Tablets Market

  • The report on global canine oral chewable tablets market gives historical, current and future market sizes (US$ Bn) based on composition type, drug class, product availability, distribution channel and region.
  • canine oral chewable tablets market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Zoetis, Inc.,
  • Virbac AH Inc.
  • Pala-Tech Laboratories (U.S.),
  • Bayer HealthCare LLC,
  • Merck Animal Health,
  • Putney, Inc.
Canine Oral Chewable Tablets Market

Drivers And Restraints

Rise in the expenditure in animal welfare and wellness, wider availability of the canine oral chewable tablets in the market, and rise in the prevalence of various canine diseases such as tick and fleas infections, anticipated to fuel the global market over the forecast period. In addition, ease of administration of tablets compared with parenteral formulations, lack of nutrition values in the canine feed, and initiations taken by various pet organizations and NGOs for animal welfare are expected bolster the canine oral chewable tablets market over the forecast years. However, stringent regulatory policies for the approval of veterinary formulations, lack of awareness about the canine oral chewable tablets in rural areas, high cost of the products, and withdrawn of drugs from the market such as levothyroxine sodium due to FDA warning regarding the lack of approval might hinder the global market growth in the coming future.


North-America got significant share

Canine Oral Chewable Tablets Market

Geographically, canine oral chewable tablets market is segmented into the following regions Viz. Europe, Latin America, Asia Pacific, North America, and the Middle East and Africa. North America holds a significant share in global canine oral chewable tablets owing to increase in the adoption of canines (according to American Pet Products Association, approximately 78 Mn canines were owned in the U.S.), rise in the awareness of canine’s health, growth in the expenditure on animal welfare, increase in the research and development activities for the innovation of new products for chronic canine diseases might fuel the in the region. Asia Pacific accounts for key share, which is attributed to increasing in the prevalence of various canine microbial diseases due to unhygienic conditions, a rise in the expenditure on animal welfare, and diversification of business segment in Asia Pacific region by various manufacturers might bolster the canine oral chewable tablets market in Asia Pacific region. Europe holds a major share owing to increase the awareness about pet’s health, a rise in the prevalence of various canine diseases, lack of nutrition fortified canine feed, and rise in research and development activities for the canine oral chewable tablets market might propel the market growth in Europe region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In February 2016, Zoetis Inc. received the FDA approval for Simparica, canine oral chewable tablets for the treatment of ticks and fleas infection
  • In March 2016, Virbac launched Movoflextm soft chews, as the canine joint health supplementation in the U.S.

Key

Report Outline

Canine Oral Chewable Tablets Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

1. Executive summary

2. Global Canine Oral Chewable Tablets Market Introduction
2.1. Global Canine Oral Chewable Tablets Market– Taxonomy
2.2. Global Canine Oral Chewable Tablets Market–Definitions
2.2.1. Composition Type
2.2.2. Drug Class

3. Global Canine Oral Chewable Tablets Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Canine Oral Chewable Tablets Market Dynamics – Factors Impact Analysis
3.6. Global Canine Oral Chewable Tablets Market– Recent Market Introductions

4. Global Canine Oral Chewable Tablets Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. Global Canine Oral Chewable Tablets Market Forecast, By Composition Type, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Botanically Synthesized
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Chemically Synthesized
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis

6. Global Canine Oral Chewable Tablets Market Forecast, By Drug Class, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Analgesics
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Anti-infective
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Anti-ulcers
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Vitamins & Minerals
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Cardiovascular Drugs
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis

7. Global Canine Oral Chewable Tablets Market Forecast, By Application, 2013 – 2017 and Forecast, 2018 – 2024
7.1. Gastrointestinal Diseases
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Cardiovascular Disorders
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Disorders
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Cardiovascular Disorders
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis

8. Global Canine Oral Chewable Tablets Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024
8.1. Veterinary Clinics
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Veterinary Pharmacies
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Veterinary Pharmacies
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis

9. Global Canine Oral Chewable Tablets Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
9.1. North America
9.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Canine Oral Chewable Tablets Market- Opportunity Analysis Index – By Drug Class, By Composition Type, By Application, By Distribution Channel, and Region, 2018 – 2024

10. North America Canine Oral Chewable Tablets Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.1. Botanically Synthesized
10.1.2. Chemically Synthesized
10.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Analgesics
10.2.2. Anti-infective
10.2.3. Anti-ulcers
10.2.4. Vitamins & Minerals
10.2.5. Cardiovascular Drugs
10.2.6. Others
10.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Gastrointestinal Diseases
10.3.2. Cardiovascular Disorders
10.3.3. Infectious Diseases
10.3.4. Nutritional Supplements
10.3.5. Others
10.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Veterinary Clinics
10.4.2. Veterinary Pharmacies
10.4.3. Online Veterinary Pharmacies
10.4.4. Others
10.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Canine Oral Chewable Tablets Market- Opportunity Analysis Index – By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024
10.7. North America Canine Oral Chewable Tablets Market Dynamics – Trends

11. Europe Canine Oral Chewable Tablets Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Botanically Synthesized
11.1.2. Chemically Synthesized
11.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Analgesics
11.2.2. Anti-infective
11.2.3. Anti-ulcers
11.2.4. Vitamins & Minerals
11.2.5. Cardiovascular Drugs
11.2.6. Others
11.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Gastrointestinal Diseases
11.3.2. Cardiovascular Disorders
11.3.3. Infectious Diseases
11.3.4. Nutritional Supplements
11.3.5. Others
11.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Veterinary Clinics
11.4.2. Veterinary Pharmacies
11.4.3. Online Veterinary Pharmacies
11.4.4. Others
11.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Canine Oral Chewable Tablets Market- Opportunity Analysis Index – By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024
11.7. Europe Canine Oral Chewable Tablets Market Dynamics – Trends

12. Asia-Pacific Canine Oral Chewable Tablets Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
12.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Botanically Synthesized
12.1.2. Chemically Synthesized
12.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Analgesics
12.2.2. Anti-infective
12.2.3. Anti-ulcers
12.2.4. Vitamins & Minerals
12.2.5. Cardiovascular Drugs
12.2.6. Others
12.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gastrointestinal Diseases
12.3.2. Cardiovascular Disorders
12.3.3. Infectious Diseases
12.3.4. Nutritional Supplements
12.3.5. Others
12.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Veterinary Clinics
12.4.2. Veterinary Pharmacies
12.4.3. Online Veterinary Pharmacies
12.4.4. Others
12.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Canine Oral Chewable Tablets Market- Opportunity Analysis Index – By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024
12.7. Asia-Pacific Canine Oral Chewable Tablets Market Dynamics – Trends

13. Latin America Canine Oral Chewable Tablets Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
13.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1. Botanically Synthesized
13.1.2. Chemically Synthesized
13.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Analgesics
13.2.2. Anti-infective
13.2.3. Anti-ulcers
13.2.4. Vitamins & Minerals
13.2.5. Cardiovascular Drugs
13.2.6. Others
13.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Gastrointestinal Diseases
13.3.2. Cardiovascular Disorders
13.3.3. Infectious Diseases
13.3.4. Nutritional Supplements
13.3.5. Others
13.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Veterinary Clinics
13.4.2. Veterinary Pharmacies
13.4.3. Online Veterinary Pharmacies
13.4.4. Others
13.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Canine Oral Chewable Tablets Market- Opportunity Analysis Index – By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024
13.7. Latin America Canine Oral Chewable Tablets Market Dynamics – Trends

14. Middle East & Africa Canine Oral Chewable Tablets Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
14.1. Composition Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.1. Botanically Synthesized
14.1.2. Chemically Synthesized
14.2. Drug Class Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Analgesics
14.2.2. Anti-infective
14.2.3. Anti-ulcers
14.2.4. Vitamins & Minerals
14.2.5. Cardiovascular Drugs
14.2.6. Others
14.3. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Gastrointestinal Diseases
14.3.2. Cardiovascular Disorders
14.3.3. Infectious Diseases
14.3.4. Nutritional Supplements
14.3.5. Others
14.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Veterinary Clinics
14.4.2. Veterinary Pharmacies
14.4.3. Online Veterinary Pharmacies
14.4.4. Others
14.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Canine Oral Chewable Tablets Market- Opportunity Analysis Index – By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2018 – 2024
14.7. MEA Canine Oral Chewable Tablets Market Dynamics – Trends

15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Zoetis, Inc. (Pfizer) (U.S)
15.2.2. Virbac AH Inc. (France)
15.2.3. Elanco (Eli Lilly and Co.) (U.S.)
15.2.4. Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
15.2.5. Pala-Tech Laboratories (U.S.)
15.2.6. Bayer HealthCare LLC, (Bayer AG) (Germany)
15.2.7. Merck Animal Health (Merck &co. Inc.) (U.S.)
15.2.8. Putney, Inc. (Dechra Pharmaceuticals) (U.K.)

16. Research Methodology

17. Key Assumptions and Acronyms


Report

Company Profile

  • Zoetis, Inc. (Pfizer) (U.S)
  • Virbac AH Inc. (France)
  • Elanco (Eli Lilly and Co.) (U.S.)
  • Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
  • Pala-Tech Laboratories (U.S.)
  • Bayer HealthCare LLC, (Bayer AG) (Germany)
  • Merck Animal Health (Merck &co. Inc.) (U.S.)
  • Putney, Inc. (Dechra Pharmaceuticals) (U.K.)

Description

Canine Oral Chewable Tablets Market are the oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and fleas infections, and among others. Various additives and flavouring agents are used in the formulation of canine oral chewable tablets for masking the unpleasant taste and odour of the drugs. The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately. The global canine oral chewable tablets market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the global market. For instance, in December 2015, Boehringer Ingelheim acquired Merial (Sanofi animal health) for strengthening its product portfolio. In addition, in May 2014, Merck Animal Health received the FDA approval for its drug Bravecto (fluralaner) used in the treatment of fleas and ticks infections. Moreover, in December 2014, Putney, Inc. launched the Carprofen canine oral chewable tablets for the treatment of pain and inflammation.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX